30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Strategic Initiatives

ISTO Technologies Acquired by Private Equity Firm -

The commercial operations of ISTO Technologies, an orthobiologics company, were acquired by private equity firm Thompson Street Capital Partners. Transaction terms were not disclosed.

ISTO's portfolio includes InQu® Bone Graft Extender & Substitute, Influx® Trabecular Bone Graft and CellPoint® Concentrated Bone Marrow Aspirate System.

The company was established in 1997 and began to secure U.S. patents and attract funding shortly thereafter. Thompson Street plans to make investments and complementary acquisitions to support ISTO's product development, salesforce expansion and increase the company’s reach within spine and orthopaedics.

Sources: ISTO Technologies, ORTHOWORLD Inc.


This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.